Steinkogler F J, Scholda C D
Oculoplastic Department, University Eye Clinic Vienna, Austria.
Ophthalmic Surg. 1993 Nov;24(11):755-8.
Both diagnostic and therapeutic problems remain in the treatment of basal cell carcinomas of the eyelid. Incorrect initial diagnosis and resulting inadequate treatment can lead to the loss of the bulbus. Inadequate follow up may result in failure to detect a recurrent tumor. We retrospectively studied 226 patients with basal cell carcinoma of the eyelid who had surgery some time between 1980 and 1989. In 179 patients, a primary lid tumor was removed; the recurrence rate for these patients was 6.1%. Forty-seven patients had surgery for secondary eyelid basaliomas; the recurrence rate for these patients was 14.8%. These recurrence rates correlated clearly with the horizontal extent and depth of the tumor, and with the appearance of the sclerodermiform type. The fact that recurrences were found after 3 years demonstrates the importance of long-term follow up in these patients, especially in those with secondary tumors and tumors of exceptional height.
眼睑基底细胞癌的治疗中仍存在诊断和治疗方面的问题。初始诊断错误以及由此导致的治疗不足可能会导致眼球丧失。随访不足可能会导致无法检测到复发性肿瘤。我们回顾性研究了1980年至1989年期间接受手术治疗的226例眼睑基底细胞癌患者。179例患者切除了原发性眼睑肿瘤;这些患者的复发率为6.1%。47例患者因继发性眼睑基底细胞瘤接受手术;这些患者的复发率为14.8%。这些复发率与肿瘤的水平范围和深度以及硬皮病样类型的外观密切相关。3年后发现复发这一事实表明了对这些患者进行长期随访的重要性,尤其是对那些患有继发性肿瘤和高度异常肿瘤患者。